Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the Commission related to tertiary-Butylhydroquinone (TBHQ)

EFSA Journal

Volumn 2, Issue 10, 2004, Pages

[No Author Info available]

Author keywords

Antioxidant; CAS Registry Number 1948 33 0; Food Additive; other CAS Numbers 123477 69 0, 140627 33 4, 29863 17 0, 68816 56 8; TBHQ; tertiary Butylhydroquinone

Indexed keywords

EID: 85078376315     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2004.84     Document Type: Article

References (117)

1. Abdo, K.M. and Kari, F.W. (1996) The sensitivity of the NTP bioassay for carcinogen hazard evaluation can be modulated by dietary restriction. Exp. Toxic. Pathol. 48, 129–137.
2. Alison, R.H., Capen, C.C., Prentice, D.E. (1994) Neoplastic lesions of questionable significance to humans. Toxicol Pathol. 22(2), 179–186.
3. Altmann, H.-J., Grunow, W., Mohr, U., Richter-Reichhelm, H.B. and Wester, P.W. (1986) Effects of BHA and related phenols on the forestomach of rats. Food Chem. Toxicol. 24, 1183–1188.
4. Altmann, H.-J., Grunow, W., Wester, P.W. and Mohr, U. (1985) Induction of forestomach lesions by butylhydroxyanisole and structurally related substances. Arch. Toxicol. 8 (Suppl.), 114–116.
5. Astill, B.D., Blakeley, R.V. and Cantor, E.E. (1967a) The metabolic fate of TBHQ in rats and dogs and of TBHQ-14C in rats. Unpublished report of the Biochemical Laboratory, Eastman Kodak. (As cited by WHO 1998).
6. Astill, B.D., Cantor, E.E., Ely, T.S., Jones, W.H. and Uskavitch, R.J. (1967c) The Oral ingestion of t-butylhydroquinone (TBHQ) by humans; clinical observations and metabolic fate. Unpublished report from the Laboratory of Industrial Medicine, Eastman Kodak. (As cited by WHO 1998).
7. Astill, B.D., Cantor, E.E. and McEwan, D.B. (1967b) Long-term feedings of TBHQ to rats and dogs: Urinary conjugate excretions, serum TBHQ levels and autopsied fat analyses. Unpublished report of the Biochemical Laboratory, Eastman Kodak. (As cited by WHO 1998).
8. Astill, B.D. and Mulligan, L.T. (1977) Phenolic antioxidants and the inhibition of hepatotoxicity from N-dimethylnitrosamine formed in situ in the rat stomach. Food Cosmet. Toxicol. 15, 167–171.
9. Astill, B.D. and Walton, D.A. (1968) Distribution of radioactivity in pregnant rats receiving 14C-labelled TBHQ. Unpublished report from the Biochemical Laboratory, Eastman Kodak. (As cited by WHO 1998).
10. Astill, B.D., Blakeley, R.V., Cantor, E.E., Tischer, K.S., Walton, D.A., McEwan, D.B., Jones, W.H., and Ely, T.S. (1968) Biochemical studies on tert-butylhydroquinone (TBHQ): A summary. Unpublished report from the Laboratory of Industrial Medicine, Eastman Kodak. (As cited by WHO 1998).
11. Beilman, J.J. and Barber, E.D. (1985) Evaluation of mono-t-butylhydroquine in the CHO/HGPRT forward mutation assay. Unpublished report no.85–0061 from Health and Environment Laboratories, Eastman Kodak Co., Rochester, NY, USA. (As cited by WHO 1998).
12. Bergmann, B., Dohrmann, J.K. and Kahl, R. (1992) Formation of the semiquinone anion radical from tert-butylquinone and from tert-butylhydroquinone in rat liver microsomes. Toxicology 74, 127–133.
13. Boehme, M.A. and Branen, A.L. (1977) Effects of food antioxidants on prostaglandin biosynthesis. J. Food Sci. 42, 1243–1246. (As cited by WHO 1998).
14. Capen, C.C., Dybing, E., Rice J.M. and Wilbourn J.D., eds (1999) Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. IARC Scientific Publications No. 147, Lyon, IARC Press. monographs.iarc.fr/htdocs/iarcpubs/pub147/pub147consensus.html.
15. CEC (1989) Commission of the European Communities, Reports of the Scientific Committee for Food, twenty-second series.
16. CEC (1991) Commission of the European Communities. Commission directive of 14 May 1991 on infant formulae and follow-on formulae (91/321/EEC).
17. CEC (1993) Commission of the European Communities. Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food. Thirty first series. Luxembourg: Office for official Publications of the European Communities.
18. Cosmetic Ingredient Review Expert Panel (1991) Final report on the safety assessment of t-butyl hydroquinone, Journal of the American College of Toxicology 10, 1–7.
19. Colovai, A.I., Herdan, J., Popovici, C., Mihai, C., Grigoras, C., Voiculetz, N. and Nicolescu-Duvaz, I. (1993) In vitro inhibition of DNA adduct formation by hindered hydroquinols and quinones. Carcinogenesis 14, 1137–1141.
20. Dobo, K.L. and Eastmond, D.A. (1994) Role of oxygen radicals in the chromosomal loss and breakage induced by the quinone-forming compounds, hydroquinone and tert-butylhydroquinone. Environ. Mol. Mutagen. 24, 293–300.
21. Eastman Chemical Company (2003) Toxicological Assessment of Tertiary-butyl-hydroquinone (TBHQ) Degradation Products. Unpublished statement sent to EFSA on 19 December 2003.
22. Eastman Chemical Products (1968) Two-year chronic feeding studies with tertiary butyl hydroquinone (TBHQ) in dogs. Unpublished report from the Food and Drug Research Laboratories, Inc.
23. Fassett, D.W., Roudabush, R.L. and Terhaar, C.J. (1965) Reproduction study on rats fed monotertiary butyl hydroquinone. Unpublished report from the Laboratory of Industrial Medicine, Eastman Kodak.
24. Fassett, D.W., Terhaar, C.J. and Astill, B.D. (1968) Summary of the safety evaluation of monotertiary butyl hydroquinone. Unpublished report from the Laboratory of Industrial Medicine, Eastman Kodak.
25. Food Chemical Codex (FCC), National Research Council, Food and Nutrition Board, Committee on Codex Specifications. 3rd Edition, Washington D.C.: Nat. Acad. Pr. (1981). ISBN: 0-309-03090-0.
26. Fukushima, S., Shibata, M.-A., Hirose, M., Kato, T., Tatematsu, M. and Ito, N. (1991) Organ-specific modification of tumour development by low-dose combinations of agents in a rat wide-spectrum carcinogenesis model. Jpn. J. Cancer Res. 82, 784–792.
27. Giri, A.K., Sen, S., Talukder, G. and Sharma, A. (1984) Mutachromosomal effects of tert-butylhydroquinone in bone marrow cells of mice. Food Chem. Toxicol. 22, 459–460.
28. Hageman, F.J., Verhagen, H. and Kleinjans, J.C.S. (1988) Butylated hydroxyanisole, butylated hydroxytoluene and tert-butylhydroquinone are not mutagenic in the Salmonella/microsome assay using new tester strains. Mutat. Res. 208, 207–211.
29. Hagiwara, A., Hirose, M., Miyata, Y., Fukushima, S. and Ito, N. (1989) Modulation of N-butyl-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis by post-treatment with combinations of three phenolic antioxidants. J. Toxicol. Pathol. 2, 33–39.
30. Hamama, A.A. and Nawar, W.W. (1991). Thermal decomposition of some phenolic antioxidants. J. Agric. Food Chem. 39, 1063–1069.
31. Hasegawa, R., Tiwawech, D., Hirose, M., Takaba, K., Hoshiya, T., Shirai, T. and Ito, N. (1992) Suppression of diethylnitrosamine-initiated preneoplastic foci development in the rat liver by combined administration of four antioxidants at low doses. Jpn. J. Cancer Res. 83, 431–437. (As cited by WHO 1998).
32. Hayashi, M., Tice, R.R., MacGregor, J.T., Anderson, D., Blakey, D.H., Kirsh-Volders, M., Oleson, F.B., Pacchierotti, F., Romagna, F., Shimada, H. et al. (1994) In vivo rodent erythrocyte micronucleus assay. Mutat. Res. 312, 293–304.
33. Hirose, M., Inoue, T., Asamoto, M., Tagawa, Y. and Ito, N. (1986) Comparison of the effects of 13 phenolic compounds in induction of proliferative lesions of the forestomach and increase in the labelling indices of the glandular stomach and urinary bladder epithelium of Syrian hamsters. Carcinogenesis 7, 1285–1289.
34. Hirose, M., Masuda, A., Fukushima, S. and Ito, N. (1988) Effects of subsequent antioxidant treatment on 7,12-dimethylbenz[a]anthracene-initiated carcinogenesis of the mammary gland, ear duct and forestomach in Sprague-Dawley rats. Carcinogenesis 9, 101–104.
35. Hirose, M., Yada, H., Hakoi, K., Takahashi, S. and Ito, N. (1993) Modification of carcinogenesis by α-tocopherol, t-butylhydroquinone, propyl gallate and butylated hydroxytoluene in a rat multi-organ carcinogenesis model. Carcinogenesis 14, 2359–2364.
36. IARC (2001) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 79, Some thyrotropic agents. Lyon, IARC Press.
37. Institute of European Food Studies, 1999. Food Based Dietary Guidelines, British Journal of Nutrition, 81, S2 (whole supplement).
38. Irache, J.M., Diaz-Garcia, J.M. and Vega, F.A. (1993) Stability of some phenolic antioxidants in fatty preparations. Pharmaceutica Acta Helvetiae 68, 135–140.
39. Ito, N. and Fukushima, S. (1989) Promotion of urinary bladder carcinogenesis in experimental animals. Exp. Pathol. 36, 1–15.
40. Ito, N., Hagiwara, A., Shibata, M., Ogiso, T. and Fukushima, S. (1982) Induction of squamous cell carcinoma in the forestomach of F344 rats treated with butylated hydroxyanisole. Gann 73, 332–334. (As cited by WHO 1998).
41. Ito, N., Tsuda, H., Tatematsu, M., Inoue, T., Tagawa, Y., Aoki, T., Uwagawa, S., Kagawa, M., Ogiso, T., Masui, T., Imaida, K., Fukushima, S. and Asamoto, M. (1988) Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats – An approach for a new medium-term bioassay system. Carcinogenesis 9, 387–394.
42. Kahl, R., Weinke, S. and Kappus, H. (1989) Production of reactive oxygen species due to metabolic activation of butylated hydroxyanisole. Toxicology 59, 179–194.
43. Kapinya, K.J., Harms, U., Harms, C., Blei, K., Katchanov, J., Dirnagl U. and Hörtnagl, H. (2003) Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischemia in vivo. Journal of Neurochemistry 84, 1028–1039.
44. Kari, F.W., Bucher, J., Eustis, S.L., Haseman, J.K. and Huff, J.E. (1992) Toxicity and carcinogenicity of hydroquinone in F344/N rats and B6C3F1 mice. Food Chem. Toxicol. 30, 737–747.
45. Kawabe, M., Takaba, K., Yoshida, Y and Hirose, M. (1994) Effects of combined treatment with phenolic compounds and sodium nitrite on two-stage carcinogenesis and cell proliferation in the rat stomach. Jpn. J. Cancer Res. 85, 17–25.
46. Kim, C.M. and Pratt, D.E. (1990). Degradation products of 2-tert-butylhydroquinone at frying temperature. J. Food Science 55(3), 847–850 and 853.
47. Krasavage, W.J. (1977) Evaluation of the teratogenic potential of tertiary butylhydroquinone (TBHQ) in the rat. Teratology 16, 31–33.
48. Krasavage, W.J. and Faber, W.D. (1983) Tertiary butylhydroquinone (TBHQ): Dominant lethal assay in rats. Unpublished report from Health and Environment Laboratories, Eastman Kodak Co., Rochester, NY, USA.
49. Krasavage, W.J. and O'Donoghue, J.L. (1984) Lack of lung damage in mice following administration of tertiary butylhydroquinone. Drug Chem. Toxicol. 7, 335–343. (As cited by WHO 1998).
50. Krasavage, W.J. and Terhaar, C.J. (1970) The reproductive performance of rats fed monotertiary butyl hydroquinone: A single generation study. Unpublished report from Toxicology Laboratory, Eastman Kodak.
51. Li, Y. and Trush, M.A. (1994) Reactive oxygen-dependent DNA damage resulting from the oxidation of phenolic compounds by a copper-redox cycle mechanism. Cancer Res., 54 (Suppl.), 1895s–1898s.
52. Li, Y., Seacat, A., Kuppusamy, P., Zweier, J.L., Yager, J.D. and Trush, M.A. (2002) Copper redox-dependent activation of 2-tert-butyl(1,4)hydroquinone: formation of reactive oxygen species and induction of oxidative DNA damage in isolated DNA and cultured rat hepatocytes. Mutation Res. 518, 123–133.
53. Lin, F.S., Warner, C.R., and Fazio, T. (1981). Alteration of phenolic antioxidants in heated vegetable oil. J. Am. Oil Chem. Soc. 58 (7), 789–792.
54. Litton Bionetics (1982a) Mutagenicity evaluation of EK81-0318 (TBHQ) in the mouse lymphoma forward mutation assay. Unpublished report no.20989 from Litton Bionetics Inc.
55. Litton Bionetics (1982b) Mutagenicity evaluation of EK 81–0318 (TBHQ) in the mouse micronucleus test. Unpublished report no. 20996 from Litton Bionetics Inc.
56. Litton Bionetics (1985) Mutagenicity evaluation of EK 81–0318 (TBHQ) in the mouse bone marrow cytogenetic assay. Unpublished report no.22202 from Litton Bionetics Inc.
57. Liu, R.M., Vasiliou, V., Zhu, H., Duh, J.-L., Tabor, M., Puga, A., Nebert, D.W., Sainsbury, M. and Shertzer, H.G. (1994) Regulation of [Ah] gene battery enzymes and glutathione levels by 5,10-dihydroindeno[1,2-b]indole in mouse hepatoma cell lines. Carcinogenesis 15, 2347–2352. (As cited by WHO 1998).
58. Liu, R.M., Hu, H., Robison, T.W. and Forman, H.J. (1996b) Increased gamma-glutamylcysteine synthetase and gamm-glutamyl transpeptidase activities enhance resistance of rat lung epithelial L2 cells to quinone toxicity. Am. J. Respir. Cell Mol. Biol. 14, 192–197. (As cited by WHO 1998).
59. Matsuoka, A., Matsui, M., Miyata, N., Sofuni, T. and Ishidate, M. (1990) Mutagenicity of 3-tert-butyl-4-hydroxyanisole (BHA) and its metabolites in short-term test in vitro. Mutat. Res. 241, 125–132.
60. Morimoto, K., Tsuji, J., Iio, T., Miyata, N., Uchida, A., Osawa, R., Kitsutaka, H. and Takahashi, A. (1991) DNA damage in forestomach epithelium from male F344 rats following oral administration of tert-butylquinone, one of the forestomach metabolites of 3-BHA. Carcinogenesis 12, 703–708.
61. Mueller, K.R. and Lockhart, H.B. (1983) In vitro genetic activity report: Evaluation of mono-tertiary butylhydroquinone in the Ames Salmonella/microsome bacterial mutagenesis test. Unpublished report from Health, Safety and Human Factors Laboratory, Eastman Kodak Co., Rochester, NY, USA.
62. Mukherjee, A., Talukder, G. and Sharma, A. (1989) Sister chromatid exchanges induced by tertiary butyl hydroquinone in bone marrow cells of mice. Environ. Mol. Mutagen. 13, 234–237.
63. Nagai, F., Okubo, T., Ushiyama, K., Satoh, K. and Kano, I. (1996) Formation of 8-hydroxydeoxyguanosine in calf thymus DNA treated with tert-butylhydroquinone, a major metabolite of butylated hydroxyanisole. Toxicol. Lett. 89, 163–167.
64. Nakagawa, Y. (1996) Effects of dicoumarol on cytotoxicity caused by tert- butylhydroquinone in isolated rat hepatocytes. Toxicol. Lett. 84, 63–68. (As cited by WHO 1998).
65. Nakagawa, Y. and Moldeus, P. (1992) Cytotoxicity effects of phenylhydroquinone and some hydroquinones on isolated rat hepatocytes. Biochem. Pharmacol. 44, 1059–1065. (As cited by WHO 1998).
66. Nakagawa, Y., Nakajima, K., Moore, G. and Moldeus, P. (1994) On the metabolisms of 3-tert-butyl-4-hydroxyanisole- and its metabolites-induced cytotoxicities in isolated rat hepatocytes. Eur. J. Pharmacol. (Environ. Toxicol. Pharmacol. Sect.) 270, 341–348. (As cited by WHO 1998).
67. NTP (National Toxicology Program) (1995) Toxicology and carcinogenesis studies of t-butylhydroquinone (CAS No.1948-33-0) in F344/N Rats and B6C3F1 mice (feeding studies). Draft Technical Report Series No.459; NIH Publication No.95–3375). U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, N.C.
68. NTP (National Toxicology Program) (1997a) Toxicology and carcinogenesis studies of t-butylhydroquinone (CAS No.1948-33-0) in F344/N and B6C3F1 mice (Feed Studies). Technical Report Series No. 459. NIH Publication No. 97-3375. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, N.C.
69. NTP (National Toxicology Program) (1997b) Effect of dietary restriction on the toxicology and carcinogenesis studies in F344/N rats and B6C3F1 mice. Technical Report Series No. 460. NIH Publication No. 97-3376. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, N.C.
70. NTP (National Toxicology Program) (Study Number: IMM87036) Immunotoxicity of tertiary butylhydroquinone (TBQ) (CAS No. 1948-33-0). ntp-server.niehs.nih.gov/htdocs/IT-studies/imm87036.html.
71. OECD (1998) Ninth addendum to the OECD Guidelines for the testing of chemicals, Paris, February 1998.
72. Olsen, P., Bille, N., and Meyer, O. (1983) Hepatocellular neoplasms in rats induced by butylated hydroxytoluene (BHT). Acta Pharmacol. Toxicol. 53, 433–434.
73. Ono, S., Kurata, Y., Shichino, Y., Sano, M. and Fukushima, S. (1992) Synergism of environmental carcinogens and promoters on bladder cancer development initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine in F344 rats. Jpn. J. Cancer Res. 83, 955–963.
74. Peters, M.M., Lau, S.S., Dulik, D., Murphy, D., Van Ommen, B., Van Bladeren, P.J. and Monks, T.J. (1996a) Metabolism of tert-butylhydroxyquinone to S-substituted conjugates in the male Fischer 344 rat. Chem. Res. Toxicol. 9, 133–139.
75. Peters, M.M., Rivera, M.I., Jones, T.W., Monks, T.J. and Lau, S.S. (1996b) Glutathione conjugates of tert-butylhydroquinone, a metabolite of the urinary tract tumour promoter 3-tert-butylhydroxyanisole, are toxic to kidney and bladder. Cancer Res. 56, 1006–1011.
76. Phillips, B.G., Carroll, P.A., Tee, A.C. and Anderson, D. (1989) Microsome-mediated clastogenicity of butylated hydroxyanisole (BHA) in cultured Chinese hamster ovary cells: The possible role of reactive oxygen species. Mutat. Res. 214, 105–114.
77. Pinkus, R. Weiner, L.M. and Daniel, W. (1996) Role of oxidants and antioxidants in the induction of AP-1, Nf-kappaB, and glutathione S-transferase gene expression. J. Biol. Chem. 271, 13422–13429. (As cited by WHO 1998).
78. Prochaska, H.J. (1987) Mechanism of modulation of carcinogenesis by chemoprotective enzyme inducers. Importance of redox liability. Proc. Annu. Meet. Am. Assoc. Cancer Res. 28, 127. (As cited by WHO 1998).
79. Prochaska, H.J. (1994) Screening strategies for the detection of anticarcinogenic enzyme inducers. J. Nutr. Biochem. 5, 360–368. (As cited by WHO 1998).
80. Rahimtula, A.D., Jernstrom, B., Dock, L. and Moldeus, P. (1982) Effects of dietary and in vitro 2(3)-t-butyl-4-hydroxyanisole and other phenols on hepatic enzyme activities in mice. Br. J. Cancer 45, 935–944. (As cited by WHO 1998).
81. Rogers, C.G., Boyes, B.G., Matula, T.I. and Stapley, R. (1992) Evaluation of genotoxicity of tert-butylhydroquinone in a hepatocyte-mediated assay with V79 Chinese hamster lung cells and in strain D7 of Saccharomyces cerevisiae. Mutat. Res. 280, 17–27.
82. Rogers, C.G., Boyes, B.G., Matula, T.I., Neville, B. and Stapley, R. (1993) Cytotoxic and genotoxic properties of tert-butyl-p-quinone (TBQ) in an in vitro assay system with Chinese hamster V79 cells and in strain D7 of Saccharomyces cerevisiae. Mutat. Res. 299, 9–18.
83. Scamps, F., Vigues, S., Restituito, S., Campo, B. Roig, A., Charnet, P. and Valmier, J. (2000) Sarco-endoplasmic ATPase blocker 2,5-di(tert-butyl)-1, 4-benzohydroquinone inhibits N-, P-, and Q- but not T-, L-, or R-type calcium currents in central and peripheral neurons. Molecular Pharmacology 58, 18–26.
84. Schilderman, P.A.E.L., Van Maanen, J.M.S., Ten Vaarwerk, F.J., Lafleur, M.V.M., Westmijze, E.J., Ten Hoor, F. and Kleinjans, J.C.S. (1993a) The role of prostaglandin H synthase-mediated metabolism in the induction of oxidative DNA damage by BHA metabolites. Carcinogenesis 14, 1297–1302.
85. Schilderman, P.A.E.L., Van Maanen, J.M.S., Smeets, E.J., Ten Hoor, F. and Kleinjans, J.C.S. (1993b) Oxygen radical formation during prostaglandin H synthase-mediated biotransformation of butylated hydroxyanisole. Carcinogenesis 14, 347–353.
86. Schilderman, P.A.E.L., Rhijnsburger, E., Zwingmann, I. and Kleinjans, J.C.S. (1995) Induction of oxidative DNA damage and enhancement of cell proliferation in human lymphocytes in vitro by butylated hydroxyanisole. Carcinogenesis 6, 507–512.
87. Seilkop, S.K (1995) The effect of body weight on tumour incidence and carcinogenicity testing in B6C3F1 mice and F344 rats. Fundam. Appl. Toxicol. 24, 247–259.
88. Shertzer, H.G., Vasiliou, V., Liu, R.M., Tabor, M.W. and Nebert, D.W. (1995) Enzyme induction by L-buthionine (S,R)-sulfoximine in cultured mouse hepatoma cells. Chem. Res. Toxicol. 8, 431–436. (As cited by WHO 1998).
89. Shibata, M.-A., Yamada, M., Tanaka, H., Kagawa, M. and Fukushima, S. (1989) Changes in urine composition, bladder epithelial morphology, and DNA synthesis in male F344 rats in response to ingestion of bladder tumour promoters. Toxicol. Appl. Pharmacol. 99, 37–49.
90. Societe Kemin Europa (1982a). Recherche de mutagenicite sur Salmonella typhimurium HIS selon la technique de B.N. Ames sur le produit TBHQ. Unpublished report no.1PL-R-82044 prepared for Societe Kemin Europa, S.A. (As cited by WHO 1998).
91. Societe Kemin Europa (1982b). Recherche de l'eventuelle potentialite mutagene de la teriao-butylhydroquinone par la technique du micronucleus chez la souris, C.E.R.T.I. Unpublished report no.678 prepared for Societe Kemin Europa, S.A. (As cited by WHO 1998).
92. Societe Kemin Europa (1982c). Recherche d'aberrations chromosomiques par analyse de metaphases sur cellules V79, produit TBHQ, Institut Pasteur de Lille. Unpublished report no.1PL-R-82050 prepared for Societe Kemin Europa, S.A. (As cited by WHO 1998).
93. Suzuki, T., Matsuoka, T., Sawada, M., Hayashi, M., Miyata, N. and Sofuni, T. (1991) Cytotoxicity and micronucleus induction by 3-tert-butyl-4-hydroxyanisole and its metabolites in menadione- and H2O2-resistant cells. Mutat. Res. 253, 278–279.
94. Tajima, K., Hashizaki, M., Yamamoto, K. and Mizutani, T. (1991) Identification and structure characterization of S-containing metabolites of 3-tert-butyl-4-hydroxyanisole in rat urine and liver microsomes. Drug Metab. Dispos. 19, 1028–1033.
95. Tamano, S., Fukushima, S., Shirai, T., Hirose, M. and Ito, N. (1987) Modification by α-tocopherol, propyl gallate and tertiary butyl hydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl) nitrosamine. Cancer Lett. 35, 39–46.
96. Terhaar, C.J. and Krasavage, W.J. (1968a) The reproductive performance of rats fed monotertiary butyl hydroquinone. Unpublished report from the Toxicology Laboratory, Eastman Kodak.
97. Terhaar, C.J. and Krasavage, W.J. (1968b) Monotertiary butyl hydroquinone (TBHQ) in heated and unheated cottonseed oil. A six month dietary feeding study in rats. Unpublished report from the Toxicology Laboratory, Eastman Kodak.
98. Terhaar, C.J., Krasavage, W.J., Wolf, G.L. and Leonard, W.J. (1968b) Study of the tolerance of rats to monotertiary butyl hydroquinone in the diet: Final report at 20 months. Unpublished report from the Toxicology Laboratory, Eastman Kodak.
99. Terhaar, C.J., Vis, E.A. and Kesel, H.J. (1968a) Acute oral toxicity of monotertiary butylhydroquinone (TBHQ). Unpublished report from the Laboratory of Industrial Medicine, Eastman Kodak.
100. Tischer, K.S. and Walton, D.A. (1968) Dietary feeding of TBHQ and related compounds to rats and dogs: The response of liver processing enzymes and liver glucose-6-phosphatase activity. Unpublished report from the Biochemistry Laboratory, Eastman Kodak.
101. Tropp, J. and Markus, E.J. (2001) Effects of mild food deprivation on the estrous cycle of rats. Physiology and Behaviour 73, 553–559.
102. Twerdok, L.E. and Trush, M.A. (1990) Differences in quinone reductase activity in primary bone marrow stromal cells derived from C57BL/6 and DBA/2 mice. Res. Commun. Chem. Pathol. Pharmacol. 67, 375–381. (As cited by WHO 1998).
103. Unpublished technical report No. 479-F (1968). Tertiary butylhydroquinone (TBHQ) in heated cottonseed oil: Preparation of samples and evaluation for possible toxic materials, Eastman Chemical Company, Kingsport TN. (Not available for re-evaluation. As cited by Eastman Chemical Company 2003).
104. Unpublished technical report No. 489-F (1968). Investigation of the loss of tertiary butylhydroquinone (TBHQ) from cottonseed oil during heating, Eastman Chemical Company, Kingsport TN. (Not available for re-evaluation. As cited by Eastman Chemical Company 2003).
105. Unpublished technical report No. 74-F00-0603 (1974). TBHQ in food frying oil – Increased concentration in “add-back” oil in continuous frying, Eastman Chemical Company, Kingsport TN. (Not available for re-evaluation. As cited by Eastman Chemical Company 2003).
106. Valentine, R. and Montgomery, R.R. (1988) Eye irritation and inhalation lethality of tert-butylhydroquinone. Journal of the American College of Toxicology 11, 753–754.
107. Van Ommen, B., Koster, A., Verhagen, H. and Van Bladeren, P.J. (1992) The glutathione conjugates of tert-butyl hydroquinone as potent redox cycling agents and possible reactive agents underlying the toxicity of butylated hydroxyanisole. Biochem. Biophys. Res. Commun. 189, 309–314. (As cited by WHO 1998).
108. Van Raaij M.T.M. (2001) Follicular thyroid tumours in rodents. In: Factsheets for the (eco)toxicological risk assessment strategy of the National Institute for Public Health and the Environment (RIVM), Part II. Editors: R. Luttik and S.M.G.J. Pelgrom. RIVM report 601516009/2002 www.rivm.nl/bibliotheek/rapporten/601516009.pdf.
109. Vasiliou, V., Shertzer, H.G., Liu, R.M., Sainsbury, M. and Nebert, D.W. (1995) Response of [Ah] battery genes to compounds that protect against menadione toxicity. Biochem. Pharmacol. 50, 1885–1891. (As cited by WHO 1998).
110. Warner, C.R., Daniels, D.H., Lin, F.S.D., Joe, F.L., Jr., and Fazio, T. (1986). Fate of antioxidants and antioxidant-derived products in deep-fat frying and cookie baking. J. Agric. Food Chem. 34, 1–5.
111. WHO (1989) Toxicological evaluation of certain food additives and contaminants, 33rd meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series, No. 24, 3–22.
112. WHO (1996) Toxicological evaluation of certain food additives and contaminants, 44th meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series, No. 35, 3–86.
113. WHO (1998) Toxicological evaluation of certain food additives and contaminants, 49th meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series, No. 40, 3–51.
114. WHO (1999) Safety evaluation of certain food additives, 51st meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series, No. 42, 453–459.
115. Williams, G.M., Iatropoulos, M.J. and Whysner, J. (1999) Safety Assessment of butylated hydroxyanisole and butylated hydroxytoluene as antioxidant food additives. Food Chem. Toxicol. 37, 1027–1038.
116. Yoshida, Y., Hirose, M., Takaba, K., Kimura, J. and Ito, N. (1994) Induction and promotion of forestomach tumours by sodium nitrite in combination with ascorbic acid or sodium ascorbate in rats with or without N-methyl-N'-nitro-N-nitrosoguanidine pre-treatment. Int. J. Cancer 56, 124–128.
117. Zeiger, E., Anderson, B., Haworth, S., Lawler, T. and Mortelmans, K. (1992) Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals. Environ. Mol. Mutagen. 19 (Suppl. 21), 2–141.